These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 21231857
1. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Platelets; 2011; 22(3):188-95. PubMed ID: 21231857 [Abstract] [Full Text] [Related]
2. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818 [Abstract] [Full Text] [Related]
3. Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. Gremmel T, Perkmann T, Seidinger D, Koppensteiner R, Panzer S, Kopp CW, Steiner S. J Atheroscler Thromb; 2013 Feb; 20(7):630-45. PubMed ID: 23739624 [Abstract] [Full Text] [Related]
4. Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity. Lee S, Eichelberger B, Kopp CW, Panzer S, Gremmel T. Vascul Pharmacol; 2021 Feb; 136():106819. PubMed ID: 33207279 [Abstract] [Full Text] [Related]
5. Response to antiplatelet therapy is independent of endogenous thrombin generation potential. Gremmel T, Panzer S, Steiner S, Seidinger D, Koppensteiner R, Pabinger I, Kopp CW, Ay C. Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170 [Abstract] [Full Text] [Related]
6. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678 [Abstract] [Full Text] [Related]
11. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. Kapłon-Cieślicka A, Rosiak M, Postuła M, Serafin A, Kondracka A, Opolski G, Filipiak KJ. Kardiol Pol; 2013 Feb; 71(9):893-902. PubMed ID: 24065375 [Abstract] [Full Text] [Related]
12. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US. Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955 [Abstract] [Full Text] [Related]
13. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Blais N, Pharand C, Lordkipanidzé M, Sia YK, Merhi Y, Diodati JG. Thromb Haemost; 2009 Aug 26; 102(2):404-11. PubMed ID: 19652893 [Abstract] [Full Text] [Related]
18. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. J Cardiovasc Pharmacol; 2010 Nov 26; 56(5):532-9. PubMed ID: 20729752 [Abstract] [Full Text] [Related]